Bausch Health
BHC
#3735
Rank
A$4.41 B
Marketcap
$11.96
Share price
-0.40%
Change (1 day)
-1.48%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.00

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.28. In 2022 the company made an earnings per share (EPS) of -$1.00 an increase over its 2021 EPS that were of -$4.28.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.00300.47%
2022-$1.00-76.64%
2021-$4.2868.45%
2020-$2.54-68.91%
2019-$8.17-57.11%
2018-$19.04-272.22%
2017$11.06-199.29%
2016-$11.14798.7%
2015-$1.24-128.31%
2014$4.38-204.62%
2013-$4.18602.7%
2012-$0.60-171.15%
2011$0.84-143.96%
2010-$1.90-206.57%
2009$1.79-11.2%
2008$2.012.46%
2007$1.96-7.58%
2006$2.12-14.29%
2005$2.4854%
2004$1.61-500%
2003-$0.40-141.67%
2002$0.97-4.76%
2001$1.01-175%
2000-$1.35-268%
1999$0.8014.94%
1998$0.7020.83%
1997$0.5853.83%
1996$0.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.61-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.43-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA